top of page



African-specific polymorphisms in Plasmodium falciparum serine repeat antigen 5 in Uganda and Burkina Faso clinical samples do not interfere with antibody response to BK-SE36 vaccination

Arisue N, Palacpac NMQ, Ntege EH, Yeka A, Balikagala B, Kanoi BN, Bougouma EC, Tiono AB, Nebie I, Diarra A, Houard S, D'Alessio F, Leroy O, Sirima SB, Egwang TG, Horii T.

Front Cell Infect Microbiol. 2022 Dec 16;12:1058081.


Impact of exposure to malaria and nutritional status on responses to the experimental malaria vaccine ChAd63 MVA ME-TRAP in 5-17 month-old children in Burkina Faso

Morter R, Tiono AB, Nébié I, Hague O, Ouedraogo A, Diarra A, Viebig NK, Hill AVS, Ewer KJ, Sirima SB.

Front Immunol. 2022 Dec 2;13:1058227


A novel asexual blood-stage malaria vaccine candidate: PfRipr5 formulated with human-use adjuvants induces potent growth inhibitory antibodies

Takashima E, Nagaoka H, Correia R, Alves PM, Roldão A, Christensen D, Guderian JA, Fukushima A, Viebig NK, Depraetere H, Tsuboi T.

Front. Immunol., 2022 Oct 27; 13:1002430


Vaccination rates in Europe are not associated with online media intensity

Luís C, Di Marzo VR, Kaur M, Argyropoulos CD, Devane D, Stewart FA, Antoniou G, Hendrickx G, Askling HH, Hellemans M, Cohen M, Spivak O, Van Damme P, Jane Cox R, Vene S, Sibia S, Pana ZD, Olesen OF, on behalf of VACCELERATE Consortium

Journal of Science Communication 21(05)(2022)A05


Safety and immunogenicity of BK-SE36 in a blinded, randomized, controlled, age de-escalating phase Ib clinical trial in Burkinabe children

Bougouma EC, Palacpac NMQ, Tiono AB, Nebie I, Ouédraogo A, Houard S, Yagi M, Coulibaly SA, Diarra A, Tougan T, Ouedraogo AZ, Soulama I, Arisue N, Yaro JB, D’Alessio F, Leroy O, Cousens S, Horii T, Sirima SB

Front Immunol. 2022 Aug 31;13:978591


VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment

Salmanton-García J, Stewart FA, Heringer S, Koniordou M, Álvarez-Barco E, Argyropoulos CD, Themistocleous SC, Valle-Simón P, Spivak O, Součková L, Merakou C, Amélia Mendonça M, Joanna Davis R, Maria Azzini A, Askling HH, Vene S, Van Damme P, Steinbach A, Shiamakkides G, Seidel D, Olesen OF, Noula E, Macken A, Luís C, Leckler J, Launay O, Isitt C, Hellemans M, Frías-Iniesta J, Di Marzo R, Carcas AJ, Boustras G, Borobia AM, Barta I, Albus K, Akova M, Ochando J, Cohen-Kandli M, Jane Cox R, Husa P, Jancoriene L, Mallon P, Marques L, Mellinghoff SC, Nauclér P, Tacconelli E, Tóth K, Zaoutis TE, Zeitlinger M, Cornely OA, Pana ZD

Vaccine. 2022 Jul 29;40(31):4090-4097


Asexual Blood-Stage Malaria Vaccine Candidate PfRipr5: Enhanced Production in Insect Cells

Correia R, Fernandes B, Castro R, Nagaoka H, Takashima E, Tsuboi T, Fukushima A, Viebig NK, Depraetere H, Alves PM, Roldão A.

Front Bioeng Biotechnol. 2022 Jun 30;10:908509


Funders’ Perspectives on Supporting Implementation Research in Low- and Middle-Income Countries

Cardoso-Weinberg A, Alley C, Kupfer LE, Aslanyan G, Makanga M, Zicker F, Olesen OF

Glob Health Sci Pract. 2022;10(2):e2100497.


A gaps-and-needs analysis of vaccine R&D in Europe: Recommendations to improve the research infrastructure

Jungbluth S, Depraetere H, Slezak M, Christensen D, Stockhofe N, Beloeil LA

Biologicals. 2022 Feb 26:S1045-1056(22)00017-3.


Controlled Human Infection Studies: Proposals for guidance on how to design, develop and produce a challenge strain

Bekeredjian-Ding I, Trouvin JH, Depraetere H, La C, Suvarnapunya AE, Bell A, Mann A, Meij P, Bethony JM, Schellhaas L, Nazziwa WB, Karikari-Boateng E, Prachumsri JS, Salmikangas P, Smith D, Stjärnkvist P, Van Molle W, Baay M, Neels P

Biologicals. 2021 Nov;74:16-23.

bottom of page